NOT_YET_RECRUITING
Establishing a Tumor Registry of Patients With Mesonephric-like Adenocarcinoma (MLA)
To develop a database of medical information about patients with MLA in an effort to increase our understanding of the characteristics of MLA, which is the rarest form of endometrial carcinoma.
Conditions:
🦠 Mesonephric-like Adenocarcinoma
🗓️ Study Start (Actual) 31 October 2024
🗓️ Primary Completion (Estimated) 28 December 2035
✅ Study Completion (Estimated) 28 December 2037
👥 Enrollment (Estimated) 2000
🔬 Study Type OBSERVATIONAL
📊 Phase N/A
Locations:
📍 Houston, Texas, United States

📋 Eligibility Criteria

Description

    Inclusion Criteria:

    • 1. Adult patients with a diagnosis of gynecologic mesonephric-like adenocarcinoma (MLA).
    • 2. Patients can also be diagnosed with mesonephric adenocarcinoma (MA) or patients with mesonephric and mesonephric-like carcinosarcomas.
    • 3. Patients who are receiving or have received treatment at any facility, including but not limited to MD Anderson Cancer Center are eligible.
    • 4. Patients may be residents of any country and be of any ethnic background.
    • 5. Patients who request to participate in the registry, regardless of the method by which they learned of it, are eligible to participate.
    • 6. Patients who do not speak English can be eligible if accompanied by an institutional interpreter.

    Exclusion Criteria:

    • 1. Patients with other subtypes of EACs.
Ages Eligible for Study: 18 Years to N/A (ADULT, OLDER_ADULT)
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No

🗓️ Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

  • First Submitted 16 April 2024
  • First Submitted that Met QC Criteria 19 April 2024
  • First Posted 22 April 2024

Study Record Updates

  • Last Update Submitted that Met QC Criteria 19 April 2024
  • Last Update Posted 22 April 2024
  • Last Verified April 2024